HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation.

ABSTRACT:

SUBMITTER: Jin X 

PROVIDER: S-EPMC7214243 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature